These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 7714977)
1. Lewis Y antigen as detected by the monoclonal antibody BR96 is expressed strongly in prostatic adenocarcinoma. Myers RB; Srivastava S; Grizzle WE J Urol; 1995 May; 153(5):1572-4. PubMed ID: 7714977 [TBL] [Abstract][Full Text] [Related]
2. Expression of tumor-associated glycoprotein 72 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. Myers RB; Schlom J; Srivastava S; Grizzle WE Mod Pathol; 1995 Apr; 8(3):260-5. PubMed ID: 7617651 [TBL] [Abstract][Full Text] [Related]
3. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate. Sheridan T; Herawi M; Epstein JI; Illei PB Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190 [TBL] [Abstract][Full Text] [Related]
4. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia. Jack GS; Brash AR; Olson SJ; Manning S; Coffey CS; Smith JA; Shappell SB Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584 [TBL] [Abstract][Full Text] [Related]
6. Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines. Sakamoto J; Furukawa K; Cordon-Cardo C; Yin BW; Rettig WJ; Oettgen HF; Old LJ; Lloyd KO Cancer Res; 1986 Mar; 46(3):1553-61. PubMed ID: 3510728 [TBL] [Abstract][Full Text] [Related]
7. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases. Tavora F; Epstein JI Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142 [TBL] [Abstract][Full Text] [Related]
8. Production of monoclonal antibody against human prostatic adenocarcinoma and its immunohistochemical properties. Matsuki H; Ozono S; Yoshie T; Kubota K; Hirao Y; Konishi N; Hashimoto H; Ohshima M; Hiasa Y; Okajima E Jpn J Exp Med; 1990 Oct; 60(5):263-72. PubMed ID: 1706786 [TBL] [Abstract][Full Text] [Related]
10. TAG-72 expression in primary, metastatic and hormonally treated prostate cancer as defined by monoclonal antibody CC49. Brenner PC; Rettig WJ; Sanz-Moncasi MP; Reuter V; Aprikian A; Old LJ; Fair WR; Garin-Chesa P J Urol; 1995 May; 153(5):1575-9. PubMed ID: 7536270 [TBL] [Abstract][Full Text] [Related]
11. Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate. Ross S; Spencer SD; Holcomb I; Tan C; Hongo J; Devaux B; Rangell L; Keller GA; Schow P; Steeves RM; Lutz RJ; Frantz G; Hillan K; Peale F; Tobin P; Eberhard D; Rubin MA; Lasky LA; Koeppen H Cancer Res; 2002 May; 62(9):2546-53. PubMed ID: 11980648 [TBL] [Abstract][Full Text] [Related]
12. [Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen]. Mathieu MC; Caillaud JM Bull Cancer; 1985; 72(5):405-13. PubMed ID: 2416371 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma. Fixemer T; Remberger K; Bonkhoff H Prostate; 2003 Feb; 54(2):79-87. PubMed ID: 12497580 [TBL] [Abstract][Full Text] [Related]
15. Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions. Rehman I; Azzouzi AR; Cross SS; Deloulme JC; Catto JW; Wylde N; Larre S; Champigneuille J; Hamdy FC Hum Pathol; 2004 Nov; 35(11):1385-91. PubMed ID: 15668896 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical demonstration of prostate-specific antigen in metastases with the use of monoclonal antibody F5. Papsidero LD; Croghan GA; Asirwatham J; Gaeta J; Abenoza P; Englander L; Valenzuela L Am J Pathol; 1985 Dec; 121(3):451-4. PubMed ID: 2416221 [TBL] [Abstract][Full Text] [Related]
17. Reactivity of monoclonal antibody F36/22 with human ovarian adenocarcinomas. Croghan GA; Wingate MB; Gamarra M; Johnson E; Chu TM; Allen H; Valenzuela L; Tsukada Y; Papsidero LD Cancer Res; 1984 May; 44(5):1954-62. PubMed ID: 6370421 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder. Lane Z; Hansel DE; Epstein JI Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate. Herawi M; Epstein JI Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076 [TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma. Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]